Company
United StatesShire Human Genetic Therapies, Inc., North Reading, MA – FDA Inspections
Inspection records and compliance data for Shire Human Genetic Therapies, Inc. in North Reading, Massachusetts. 4 FDA inspections on record, last inspected January 05, 2017.
Company Profile
This profile covers Shire Human Genetic Therapies, Inc. based in North Reading, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 2
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 16, 2011. Last inspected January 5, 2017.
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 5, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1002403 |
| January 30, 2014 | VAI | Human Drugs · Drug Quality Assurance | 872432 |
| January 6, 2012 | VAI | Human Drugs · Drug Quality Assurance | 762708 |
| February 16, 2011 | NAI | Human Drugs · Drug Quality Assurance | 716751 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Nivagen Pharmaceuticals Inc
Biospectra, Inc.
Incog Biopharma Services, Inc.
3M Company
Avista Pharma Solutions, Inc. dba Cambrex
Liquidia Technologies, Inc.
Bioindustria Laboratorio Italiano Medicinali S.p.A
Boehringer Ingelheim Hellas A.E.
Avon Cosmetics Manufacturing, S. de R.L. de C.V.
BrightGene Pharmaceutical Co., Ltd.(Jiangyun Road)
Company Information
Name
Shire Human Genetic Therapies, Inc.
FEI Number
3008424653
Address
200 Riverpark Dr, North Reading, Massachusetts 01864, United States
Country
United States
ID: 1d1f96ea-a020-4019-96a3-aee02e95246e